New MCP integration bridges diseases, medications, procedures, laboratory tests, outcomes, and eligibility criteria in plain ...
The street-high consensus price target of $17.0 implies 63.9% upside potential for the stock, making UiPath, Inc. (NYSE:PATH) one of the 10 best robotics stocks to buy under $30. On April 27, 2026, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results